3,949
Views
3
CrossRef citations to date
0
Altmetric
Coronaviruses

Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution

ORCID Icon, , , , , , , , , , , , , & show all
Pages 1254-1256 | Received 08 Apr 2021, Accepted 08 Jun 2021, Published online: 22 Jun 2021

References

  • European Centre for Disease Prevention and Control. Sequencing of SARS-CoV-2: first update. 18 January 2021. ECDC: Stockholm; 2021.
  • Schiavone M, Gasperetti A, Mitacchione G, et al. Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission. Eur J Clin Invest. 2021: e13544. DOI:https://doi.org/10.1111/eci.13544
  • Ketas TJ, Chaturbhuj D, Cruz-Portillo VM, et al. Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva. bioRxiv [Preprint]. 2021. DOI:https://doi.org/10.1101/2021.03.11.434841
  • Lixenfeld AS, Künsting I, Martin EL, et al. The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization. medRxiv. 2021. DOI:https://doi.org/10.1101/2021.03.10.21252001
  • European Centre for Disease Prevention and Control. Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination. 29 March 2021. ECDC: Stockholm, 2021.